Data protection Impressum

Newsroom

Mimix’s objective, as outlined in its strategic vision, is to introduce this wound care product to the US market by the second half of 2024.

Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment

17 October 2023

The third building of the site was inaugurated in the presence (from left to right) of Stéphane Coppey, the President of the City of Monthey, Christophe Darbellay, Head of the Department of Economy and Education, and Jean-Marc Tornare, President of BioArk.

BioArk Monthey’s third building signifies exponential growth in the life sciences sector

16 October 2023

CDMOs play a crucial role in the pharmaceutical sector, serving as key partners in the drug development and production process.

Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings

16 October 2023

The primary objective of the OQI is to employ quantum technologies for the broader global benefit, emphasizing speeding up the attainment of the United Nations' Sustainable Development Goals (SDGs).

Launch of the Open Quantum Institute in Geneva

16 October 2023

Europe beckons already! (Part #2 by Jimmy Jackson)

Europe beckons already! (Part #2 by Jimmy Jackson)

11 October 2023

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Business environment

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

Sparta Commodities’ solution represents a paradigm of future-oriented, real-time market insights that elevates commodity trading to novel heights.

USD 17.5 million to expand Sparta’s intelligent commodity trading solution globally

11 October 2023

Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism.

Adiposs completes the phase I clinical trial of its flagship product ImageBAT

11 October 2023

Impaakt has raised nearly USD 8 million, underscoring its robust journey in democratizing sustainability data and impact assessment.

Geneva fintech Impaakt secures USD 8 million to transform sustainability

11 October 2023

PULSE, with its distinctive amalgamation of adaptable, future-proof infrastructure, is set to become a pivotal hub designed to uplift and expand the frontiers of biotech and various scientific ventures.

PULSE, a modular innovation center in the heart of the Health Valley

10 October 2023

1 … 47 48 49 50 51 52 53 54 55 … 140